Hyperprolactinemia is a condition where the blood contains too much prolactin, a hormone produced by the pituitary gland at the base of the brain. Normal prolactin levels are below 20 ng/mL in men and below 25 ng/mL in non-pregnant women. When levels climb above these thresholds, prolactin can disrupt reproductive function, bone health, and quality of life in both sexes.
How Prolactin Is Normally Controlled
Prolactin is unusual among pituitary hormones because the brain’s default setting is to suppress it rather than stimulate it. A group of neurons in the hypothalamus continuously releases dopamine, which travels to the pituitary and keeps prolactin secretion in check. Dopamine lands on specific receptors on prolactin-producing cells (called lactotrophs) and essentially tells them to stay quiet. When anything disrupts that dopamine signal, whether a tumor, a medication, or another condition, prolactin levels rise.
Prolactin is best known for triggering breast milk production after childbirth, which is why levels can climb as high as 500 ng/mL during pregnancy. But it also plays roles in immune function, metabolism, and reproductive regulation, making it one of the most far-reaching hormones in the body.
Common Causes
Pituitary Tumors (Prolactinomas)
The most common pathological cause is a prolactinoma, a benign tumor of the pituitary gland that overproduces prolactin. These tumors are classified by size: microadenomas are smaller than 10 mm, macroadenomas are 10 mm or larger, and giant adenomas exceed 40 mm. Size matters clinically because it correlates with how much prolactin the tumor produces. Microadenomas typically push levels below 200 ng/mL, while macroadenomas usually drive levels above 200 ng/mL, sometimes dramatically higher.
Medications
Drug-induced hyperprolactinemia is extremely common and often overlooked. Antipsychotic medications are the most frequent culprits because they directly block dopamine receptors on lactotroph cells, removing the brake on prolactin release. Both older antipsychotics (like haloperidol and chlorpromazine) and newer ones (like risperidone, paliperidone, and amisulpride) can raise prolactin significantly, though certain newer agents like quetiapine and clozapine tend to have a milder effect.
Antidepressants are another major category. SSRIs (like sertraline, fluoxetine, and paroxetine), tricyclics (like amitriptyline and clomipramine), SNRIs, and MAO inhibitors can all elevate prolactin through their effects on serotonin, which indirectly stimulates prolactin release. Anti-nausea drugs like metoclopramide and domperidone, acid-reducing medications including both H2 blockers and proton pump inhibitors, opioids, certain blood pressure medications (methyldopa, verapamil), estrogens, and some anti-seizure drugs round out a long list of potential offenders.
Other Medical Conditions
Hypothyroidism can raise prolactin because the hormone the brain releases to stimulate the thyroid also stimulates prolactin secretion. Kidney failure impairs the body’s ability to clear prolactin from the bloodstream. Chest wall trauma or irritation (including surgery or shingles affecting the chest) can trigger prolactin release through nerve pathways. Stress and intense exercise can also cause temporary elevations.
Symptoms in Women and Men
Reproductive and sexual problems are the hallmark of hyperprolactinemia, affecting roughly 85% of both women and men. In women, excess prolactin commonly disrupts the menstrual cycle, causing irregular periods or stopping them entirely. Galactorrhea, the spontaneous production of breast milk outside of pregnancy or nursing, occurs in about 52% of women. Weight gain is also more frequent in women with the condition.
Men experience many of the same underlying hormonal disruptions but present differently. Decreased libido and erectile dysfunction are the most common complaints, with galactorrhea appearing in only about 19% of men. Because men lack an obvious signal like missed periods, they often go undiagnosed longer. By the time a prolactinoma is discovered in a man, it tends to be larger, sometimes because it has grown enough to cause headaches or press on the optic nerves and affect vision.
How It’s Diagnosed
A simple blood test measuring serum prolactin is the starting point. Your doctor will want you to have blood drawn in the morning, ideally in a relaxed state, since stress and recent meals can temporarily bump levels. If the result comes back elevated, it’s often repeated to confirm.
One important lab nuance involves something called macroprolactin, a larger, biologically inactive form of the hormone that some standard tests pick up. People with high macroprolactin levels may appear to have hyperprolactinemia on paper but have no symptoms and need no treatment. Screening for macroprolactin is recommended when elevated prolactin is found without any obvious symptoms.
Another diagnostic pitfall is the “hook effect,” which occurs in about 20% of large prolactinomas. When prolactin levels are extremely high (in the thousands), the lab assay can paradoxically return a falsely low or modest number, often between 20 and 200 ng/mL. If a macroadenoma is visible on imaging but the prolactin level seems surprisingly low, the lab can rerun the test using a diluted blood sample to reveal the true level. In one documented case, an initial reading of 100 ng/mL turned out to be 6,470 ng/mL after proper dilution.
When a pituitary tumor is suspected, an MRI of the brain focused on the pituitary gland is the standard imaging study.
Treatment Approach
Not everyone with hyperprolactinemia needs treatment. If you have a small microadenoma that isn’t causing symptoms, monitoring alone is a reasonable approach. Similarly, if medication is raising your prolactin but you have no symptoms, treatment guidelines suggest leaving it alone rather than adding another drug to the mix. For people with medication-induced hyperprolactinemia who do develop bothersome symptoms like bone loss or prolonged loss of periods, hormone replacement with estrogen or testosterone can address those specific consequences.
When treatment is needed, dopamine agonist medications are the first choice. These drugs mimic dopamine’s natural action on the pituitary, suppressing prolactin production and often shrinking prolactinomas. Cabergoline, taken once or twice per week, is generally preferred over bromocriptine (taken daily) because it’s more effective and better tolerated. Cabergoline normalizes prolactin in a higher percentage of patients and causes fewer side effects like nausea and dizziness. Typical doses range from 0.5 to 2 mg per week for cabergoline, compared to 5 to 10 mg per day for bromocriptine.
Treatment results tend to be encouraging. In studies, menstrual cycles resumed in 82% of women treated with dopamine agonists, and libido improved in 57% of men.
Bone Health and Long-Term Risks
One of the most underappreciated consequences of untreated hyperprolactinemia is bone loss. Excess prolactin suppresses estrogen in women and testosterone in men, and both hormones are critical for maintaining bone density. Research has found that women with hyperprolactinemia have spinal bone mineral content about 25% lower than healthy women. Cortical bone density drops by roughly 17%, and the spongy inner bone (trabecular bone) decreases by 15 to 30%.
This translates into real fracture risk. Among untreated women with hyperprolactinemia, vertebral fractures were found in 46% of cases, compared to 20% in women taking cabergoline. The numbers are even more striking in men: 67% of untreated men had vertebral fractures versus 26% of those on treatment. These findings underscore why prolonged, untreated hyperprolactinemia, even when symptoms seem mild, can have serious skeletal consequences over time.